# A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs

> **NCT01209702** · PHASE3 · TERMINATED · sponsor: **Hoffmann-La Roche** · enrollment: 306 (actual)

## Conditions studied

- Spondylitis, Ankylosing

## Interventions

- **BIOLOGICAL:** tocilizumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01209702
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-09
- **Primary completion:** 2011-05
- **Final completion:** 2011-12
- **Target enrollment:** 306 (ACTUAL)
- **Why stopped:** Recruitment halted: Failed to achieve efficacy
- **Last updated:** 2013-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01209702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01209702, "A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01209702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*